DK486282A - Fremgangsmaade til fremstilling af 5- eller 6-hydroxy-2-benzothiazolsulfonamider - Google Patents

Fremgangsmaade til fremstilling af 5- eller 6-hydroxy-2-benzothiazolsulfonamider Download PDF

Info

Publication number
DK486282A
DK486282A DK486282A DK486282A DK486282A DK 486282 A DK486282 A DK 486282A DK 486282 A DK486282 A DK 486282A DK 486282 A DK486282 A DK 486282A DK 486282 A DK486282 A DK 486282A
Authority
DK
Denmark
Prior art keywords
hydroxy
sulphonamides
benzothiazol
preparing
benzothiazolesulfonamide
Prior art date
Application number
DK486282A
Other languages
English (en)
Inventor
Jr Otto W Woltersdorf
Harvey Schwam
Stuart R Michelson
John M Sondey
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK486282A publication Critical patent/DK486282A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms
    • C07D277/76—Sulfur atoms attached to a second hetero atom
    • C07D277/80—Sulfur atoms attached to a second hetero atom to a nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK486282A 1981-11-03 1982-11-02 Fremgangsmaade til fremstilling af 5- eller 6-hydroxy-2-benzothiazolsulfonamider DK486282A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/317,807 US4386098A (en) 1981-11-03 1981-11-03 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure

Publications (1)

Publication Number Publication Date
DK486282A true DK486282A (da) 1983-05-04

Family

ID=23235348

Family Applications (1)

Application Number Title Priority Date Filing Date
DK486282A DK486282A (da) 1981-11-03 1982-11-02 Fremgangsmaade til fremstilling af 5- eller 6-hydroxy-2-benzothiazolsulfonamider

Country Status (16)

Country Link
US (1) US4386098A (da)
EP (1) EP0079269B1 (da)
JP (1) JPS5885877A (da)
AT (1) ATE19733T1 (da)
AU (1) AU555821B2 (da)
CA (1) CA1184119A (da)
DE (1) DE3271190D1 (da)
DK (1) DK486282A (da)
FI (1) FI823720A7 (da)
GR (1) GR77056B (da)
IE (1) IE54217B1 (da)
IL (1) IL67073A0 (da)
NO (1) NO823638L (da)
NZ (1) NZ202292A (da)
PT (1) PT75777B (da)
ZA (1) ZA828003B (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746745A (en) * 1980-07-09 1988-05-24 Maren Thomas H 1,3,4-thiadiazoline-5-sulfonamides
GB2155331B (en) * 1980-07-09 1988-09-01 Florida University Of Composition for reducing intraocular pressure
US4619939A (en) * 1980-07-09 1986-10-28 University Of Florida Process for reducing intraocular pressure
US4454148A (en) * 1982-09-02 1984-06-12 Merck & Co., Inc. 5-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4975449A (en) * 1983-02-04 1990-12-04 University Of Iowa Research Foundation Topical treatment of glaucoma with 2-benzothiazolesulfonamide derivative
US4483864A (en) * 1983-02-04 1984-11-20 University Of Iowa Research Foundation Non-classical topical treatment for glaucoma
US5095026A (en) * 1983-02-04 1992-03-10 University Of Iowa Research Foundation Prodrugs of carbonic anhydrase inhibitors
US4500538A (en) * 1983-03-14 1985-02-19 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4456599A (en) * 1983-04-22 1984-06-26 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4542152A (en) * 1983-05-23 1985-09-17 Merck & Co., Inc. 5-[Phenylsulfonyl(or sulfinyl)]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
US4510155A (en) * 1983-06-02 1985-04-09 Merck & Co., Inc. 6(or 5)-Hydroxybenzothiazole-2-sulfonamide-O-sulfate salts for the topical treatment of elevated intraocular pressure
IL72070A (en) * 1983-06-20 1988-11-30 Merck & Co Inc 2-sulfamoylbenzo(b)-thiophene derivatives,their preparation and pharmaceutical compositions containing them
US4788192A (en) * 1983-06-20 1988-11-29 Merck & Co., Inc. 2-Sulfamoylbenzo(b)thiophene derivatives pharmaceutical compositions and use
US4585787A (en) * 1983-06-20 1986-04-29 Merck & Co., Inc. 5-[2(Or 3)-hydroxyphenylsulfonyl]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
US4486444A (en) * 1983-06-20 1984-12-04 Merck & Co., Inc. (Hydroxybenzoyl)thiophenesulfonamide and acyl derivatives thereof for the topical treatment of elevated intraocular pressure
ES533389A0 (es) * 1983-06-20 1985-10-16 Merck & Co Inc Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
US4622403A (en) * 1983-10-11 1986-11-11 Merck Frosst Canada, Inc. 6-H dibenz[b,f]thiepin compounds
US4668697A (en) * 1983-10-31 1987-05-26 Merck & Co., Inc. Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor
US4505923A (en) * 1983-10-31 1985-03-19 Merck & Co., Inc. Ethers of hydroxybenzothiazole-2-sulfonamide for the topical treatment of elevated intraocular pressure
US4544667A (en) * 1984-02-09 1985-10-01 Merck & Co., Inc. 2-Sulfamoylbenzo[b]furan derivatives for the treatment of elevated intraocular pressure
DE3576498D1 (de) * 1984-03-14 1990-04-19 Merck & Co Inc 2-sulfamoyl-1h-indole-derivate zur behandlung von hohem intraocularem druck.
US4840963A (en) * 1984-03-14 1989-06-20 Merck & Co., Inc. 2-Sulfamoyl-1H-indole derivatives for the treatment of elevated intraocular pressure
IT1176613B (it) * 1984-08-14 1987-08-18 Ravizza Spa Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
EP0189690B1 (en) * 1984-12-12 1989-03-01 Merck & Co. Inc. Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them
US4929637A (en) * 1985-12-24 1990-05-29 Merck & Co., Inc. Substituted thiophene-2-sulfonamide antiglaucoma agents
US4914111A (en) * 1987-03-23 1990-04-03 Merck & Co., Inc. 4-Benzylthiophene (or furan)-2-sulfonamides as antiglaucoma agents
US4847289A (en) * 1987-06-08 1989-07-11 Merck & Co., Inc. Thiophene sulfonamide antiglaucoma agents
US4929549A (en) * 1989-02-08 1990-05-29 Merck & Co., Inc. 5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically active carbonic anhydrase inhibitors
US5059613A (en) * 1990-03-19 1991-10-22 Research Corporation Technologies, Inc. Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
US5091409A (en) * 1990-05-17 1992-02-25 Merck & Co., Inc. 4-alkylamino-6-(C3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides
US5216020A (en) * 1990-10-12 1993-06-01 Merck & Co., Inc. Substituted 4,5-dihydrothieno(2,3-b)thiophene-2-sulfonamides and 6,6-dioxides thereof
SG84487A1 (en) 1991-04-17 2001-11-20 Merck & Co Inc Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a b-adrenergic antagonist
US5300499A (en) * 1992-09-02 1994-04-05 Allergan, Inc. 5-substituted 3-thiophene sulfonamides as antiglaucoma agents
US5519040A (en) * 1994-04-29 1996-05-21 Allergan Substituted thiazole sulfonamides as antiglaucoma agents
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6316443B1 (en) 1994-08-04 2001-11-13 Merck & Co., Inc. Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
US5789435A (en) * 1995-05-22 1998-08-04 Advanced Research And Technology Institute Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight
US6156785A (en) * 1998-01-23 2000-12-05 Merck Sharp & Dohme B.V. Method for increasing oxygen tension in the optic nerve and retina
EP1251862B1 (en) * 2000-01-18 2008-10-01 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
US6548535B2 (en) * 2000-01-18 2003-04-15 Merck & Co., Inc. Method for treating ocular hypertension
US20020055458A1 (en) * 2000-08-11 2002-05-09 Einar Stefansson Method for the prevention and treatment of retinopathy
US20040254230A1 (en) * 2001-12-03 2004-12-16 Ogidigben Miller J. Method for treating ocular hypertension
EP1487438A4 (en) * 2002-03-15 2007-08-15 Merck & Co Inc COMPOSITIONS AND METHODS FOR TREATING GLUCKOM AND OKULAR HYPERTENSION
AU2003233731A1 (en) * 2002-06-06 2003-12-22 Xavier Billot 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
CA2488802A1 (en) * 2002-06-14 2003-12-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
WO2003105868A1 (en) * 2002-06-17 2003-12-24 Merck & Co., Inc. Novel maxi-k channel blockers, methods of use and process for making the same
WO2003105781A2 (en) * 2002-06-17 2003-12-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
AU2003247533B2 (en) * 2002-06-17 2008-09-18 Merck & Co., Inc. Novel maxi-k channel blockers, methods of use and process for making the same
WO2004019938A1 (en) * 2002-08-28 2004-03-11 Merck Frosst Canada & Co. Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
WO2004037786A2 (en) * 2002-10-25 2004-05-06 Merck Frosst Canada & Co. 2-pyrrolidones as ep4 receptor agonists
CA2519899A1 (en) * 2003-03-27 2004-10-14 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
EP2156833B1 (en) * 2007-05-11 2011-11-30 Santen Pharmaceutical Co., Ltd Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
US8332007B2 (en) * 2009-01-12 2012-12-11 The Board Of Trustees Of The University Of Illinois Quantitative three-dimensional mapping of oxygen tension

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2595334A (en) * 1950-04-08 1952-05-06 American Cyanamid Co Benzothiazolesulfonamides and method of preparing the same
US3519630A (en) * 1969-02-06 1970-07-07 Pennsalt Chemicals Corp Antibacterial and antifungal treatment with sulfones
ATE9059T1 (de) * 1980-01-28 1984-09-15 Merck & Co. Inc. Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.

Also Published As

Publication number Publication date
NO823638L (no) 1983-05-04
NZ202292A (en) 1986-01-24
PT75777A (en) 1982-12-01
FI823720L (fi) 1983-05-04
IE54217B1 (en) 1989-07-19
ATE19733T1 (de) 1986-05-15
EP0079269A1 (en) 1983-05-18
CA1184119A (en) 1985-03-19
FI823720A0 (fi) 1982-11-01
IL67073A0 (en) 1983-02-23
JPS5885877A (ja) 1983-05-23
ZA828003B (en) 1984-07-25
GR77056B (da) 1984-09-05
AU9004882A (en) 1983-05-12
FI823720A7 (fi) 1983-05-04
EP0079269B1 (en) 1986-05-14
PT75777B (en) 1986-01-15
IE822618L (en) 1983-05-03
US4386098A (en) 1983-05-31
DE3271190D1 (en) 1986-06-19
AU555821B2 (en) 1986-10-09

Similar Documents

Publication Publication Date Title
DK486282A (da) Fremgangsmaade til fremstilling af 5- eller 6-hydroxy-2-benzothiazolsulfonamider
NL7900676A (nl) Werkwijze voor de vervaardiging van kunstmatige bloedvatprothesen en kunstmatige bloedvatprothese.
IT7919003A0 (it) Procedimento per la fabbricazione di impiantati nonche' impiantati realizzati con detto procedimento.
ES2057899T3 (es) Procedimiento para la preparacion estereoselectiva de derivados de la fenilisoserina.
NO163100C (no) Trifenylmetylderivater av sn-glycero-3-fosfocholin og sn-glycero-3-fosfoetanolamin og fremgangsmaate for fremstilling derav.
ATE5592T1 (de) Verfahren zur herstellung von 4'deoxydaunorubicin und 4'-deoxydoxorubicin, sowie 4'-epi-4'-trifluormethyl-sulfonyloxy-ntrifluoracetyldaunorubicin.
NO157403C (no) Middel for behandling av saar.
AR241136A1 (es) Procedimiento para preparar esteres de 6-hidroxi-2-benzotiazolsulfonamida para tratamiento topicode presion intraocular elevada"
SE8100614L (sv) Humant relaxin och sett for framstellning derav
ATE49847T1 (de) Verfahren und zusammensetzung zur bekaempfung der vitrifikation waehrend der in-vitromikrovermehrung von pflanzen.
DK585984A (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
IT7922443A0 (it) Composizione oftalmica e metodo di impiego.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
IT1143224B (it) Procedimento per la produzione di prolattina umana
NO157261C (no) Fremgangsmaate til fremstilling eller behandling av ferrokrom.
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
SU875876A1 (ru) Способ изготовления упругих элементов из сплавов на основе никелида титана
DE3576498D1 (de) 2-sulfamoyl-1h-indole-derivate zur behandlung von hohem intraocularem druck.
BG40812A3 (en) Method for preparing derivatives of pyroxycam
ES477409A1 (es) Un metodo para la fabricacion de lentes de contacto blandas.
ES513096A0 (es) "metodo de producir protesis vasculares".
IT7920669A0 (it) Manicotto protettivo per protesi di trapianto e metodo per proteggere le protesi.
NO830614L (no) Fremgangsmaate for behandling av glaukom.
IT7924440A0 (it) Metodo di preparazione di derivati delle 3-fenossi-2-propanolammine aventi quali sostituenti all'anello benzinico almeno un radicale cicloalifatico.
DK581086A (da) Fremgangsmaade til fremstilling af alkyltrifluoracetater

Legal Events

Date Code Title Description
ATS Application withdrawn